Orphan Drugs
Unique marketing status helps ring up sales for biotech firms
Published in Medical Letter on the CDC and FDA, February 2nd, 2003
"It saved my law practice," said Cloud, a Cincinnati lawyer. "It saved me from disability."
GHB is illegal in the United States, classified alongside heroin and cocaine - except for Cloud and 725 other people who suffer from a rare but dangerous complication of the sleep disorder narcolepsy.
Orphan Medical, Inc., a tiny biotechnology firm in Minnetonka, Minnesota, began selling the drug to those patients in October 2002 after receiving federal regulatory approval and agreeing to distribute it under some of the most...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Administrative Issues
Phase 2 of CBER/CDER product consolidation concludes - Quality Assurance
Surgery and trauma fellowship programs linked with better outcomes - Cancer Vaccine
Dendritic cells generated by Flt3L or GM-CSF/IL-4 generate antileukemia response - Environmental Health
Humans exposed to polychlorinated biphenyls in a residential community - Liver Cancer
Folate/methyl deficiency causes gene methylation in rat livers - Vaccine Efficacy
Varicella vaccine fails to protect against infection - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
